CVE-2006-0369

Description

MySQL 5.0.18 allows local users with access to a VIEW to obtain sensitive information via the "SELECT * FROM information_schema.views;" query, which returns the query that created the VIEW. NOTE: this issue has been disputed by third parties, saying that the availability of the schema is a normal and sometimes desired aspect of database access

Category

2.1
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.12%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/423180/30/7310/threaded mailing list
http://www.securityfocus.com/archive/1/423228/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/422491/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/423204/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/422698/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/422592/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/423432/100/0/threaded mailing list

Frequently Asked Questions

What is the severity of CVE-2006-0369?
CVE-2006-0369 has been scored as a low severity vulnerability.
How to fix CVE-2006-0369?
To fix CVE-2006-0369, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-0369 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2006-0369 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.